Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients

Detalhes bibliográficos
Autor(a) principal: Cintra,Eliane de Araújo
Data de Publicação: 2004
Outros Autores: Maciel Jr,Jayme Antunes, Araújo,Sebastião, Castro,Margaret de, Martins,Edna Freitas, Falcão,Antônio Luiz Eiras, Sardinha,Luiz A.C., Terzi,Renato G.G., Dragosavac,Desanka, Cardoso,Ana Paula Devite, Oliveira,Rosmari A.R.A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000200007
Resumo: INTRODUCTION: Patients with severe brain lesions (SBL) and brain-dead patients (BD) frequently present with vasopressin (AVP) secretion disorders. OBJECTIVE: To evaluate AVP serum levels in SBL and BD patients. DESIGN: Prospective, open label, observational trial. SETTING: A general teaching hospital. METHOD: Three groups of adult subjects (age> 18y) of both sexes were included in this study: control group: 29 healthy volunteers; SBL group: 17 patients with Glasgow Coma Scale (GCS)< 8; and BD group: 11 brain-dead patients. Samples of venous blood were collected in the morning at rest from healthy volunteers and at 8 hourly intervals over a period of 24h from SBL and BD patients for AVP determinations. Concomitantly, some clinical and laboratorial variables were also recorded. RESULTS: AVP serum levels (pg/ml) were [mean (SD); median]: control [2.2(1.1); 2.0]; SBL [5.7(6.3); 2.9]; and BD [2.6(1.0); 2.8]. AVP serum levels varied greatly in SBL patients, but without statistically significant difference in relation to the other groups (p=0.06). Hypotension (p=0.02), hypernatremia (p=0.0001), serum hyperosmolarity (p=0.0001) and urinary hypoosmolarity (p=0.003) were outstanding in BD patients when compared with SBL. CONCLUSIONS: The AVP serum levels did not demonstrate significant statistical difference between the groups, only showing a greater variability in SBL patients (manifested as serum spike levels). Hypernatremia and hyperosmolarity were present in BD patients, indicating a failure of the hypothalamic-pituitary system in AVP production and release.
id ABNEURO-1_8d51d81349f4eabcbb64051028d4246a
oai_identifier_str oai:scielo:S0004-282X2004000200007
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Vasopressin serum levels in patients with severe brain lesions and in brain-dead patientsbrain lesionbrain deathvasopressinINTRODUCTION: Patients with severe brain lesions (SBL) and brain-dead patients (BD) frequently present with vasopressin (AVP) secretion disorders. OBJECTIVE: To evaluate AVP serum levels in SBL and BD patients. DESIGN: Prospective, open label, observational trial. SETTING: A general teaching hospital. METHOD: Three groups of adult subjects (age> 18y) of both sexes were included in this study: control group: 29 healthy volunteers; SBL group: 17 patients with Glasgow Coma Scale (GCS)< 8; and BD group: 11 brain-dead patients. Samples of venous blood were collected in the morning at rest from healthy volunteers and at 8 hourly intervals over a period of 24h from SBL and BD patients for AVP determinations. Concomitantly, some clinical and laboratorial variables were also recorded. RESULTS: AVP serum levels (pg/ml) were [mean (SD); median]: control [2.2(1.1); 2.0]; SBL [5.7(6.3); 2.9]; and BD [2.6(1.0); 2.8]. AVP serum levels varied greatly in SBL patients, but without statistically significant difference in relation to the other groups (p=0.06). Hypotension (p=0.02), hypernatremia (p=0.0001), serum hyperosmolarity (p=0.0001) and urinary hypoosmolarity (p=0.003) were outstanding in BD patients when compared with SBL. CONCLUSIONS: The AVP serum levels did not demonstrate significant statistical difference between the groups, only showing a greater variability in SBL patients (manifested as serum spike levels). Hypernatremia and hyperosmolarity were present in BD patients, indicating a failure of the hypothalamic-pituitary system in AVP production and release.Academia Brasileira de Neurologia - ABNEURO2004-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000200007Arquivos de Neuro-Psiquiatria v.62 n.2a 2004reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/S0004-282X2004000200007info:eu-repo/semantics/openAccessCintra,Eliane de AraújoMaciel Jr,Jayme AntunesAraújo,SebastiãoCastro,Margaret deMartins,Edna FreitasFalcão,Antônio Luiz EirasSardinha,Luiz A.C.Terzi,Renato G.G.Dragosavac,DesankaCardoso,Ana Paula DeviteOliveira,Rosmari A.R.A.eng2004-06-23T00:00:00Zoai:scielo:S0004-282X2004000200007Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2004-06-23T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients
title Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients
spellingShingle Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients
Cintra,Eliane de Araújo
brain lesion
brain death
vasopressin
title_short Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients
title_full Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients
title_fullStr Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients
title_full_unstemmed Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients
title_sort Vasopressin serum levels in patients with severe brain lesions and in brain-dead patients
author Cintra,Eliane de Araújo
author_facet Cintra,Eliane de Araújo
Maciel Jr,Jayme Antunes
Araújo,Sebastião
Castro,Margaret de
Martins,Edna Freitas
Falcão,Antônio Luiz Eiras
Sardinha,Luiz A.C.
Terzi,Renato G.G.
Dragosavac,Desanka
Cardoso,Ana Paula Devite
Oliveira,Rosmari A.R.A.
author_role author
author2 Maciel Jr,Jayme Antunes
Araújo,Sebastião
Castro,Margaret de
Martins,Edna Freitas
Falcão,Antônio Luiz Eiras
Sardinha,Luiz A.C.
Terzi,Renato G.G.
Dragosavac,Desanka
Cardoso,Ana Paula Devite
Oliveira,Rosmari A.R.A.
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cintra,Eliane de Araújo
Maciel Jr,Jayme Antunes
Araújo,Sebastião
Castro,Margaret de
Martins,Edna Freitas
Falcão,Antônio Luiz Eiras
Sardinha,Luiz A.C.
Terzi,Renato G.G.
Dragosavac,Desanka
Cardoso,Ana Paula Devite
Oliveira,Rosmari A.R.A.
dc.subject.por.fl_str_mv brain lesion
brain death
vasopressin
topic brain lesion
brain death
vasopressin
description INTRODUCTION: Patients with severe brain lesions (SBL) and brain-dead patients (BD) frequently present with vasopressin (AVP) secretion disorders. OBJECTIVE: To evaluate AVP serum levels in SBL and BD patients. DESIGN: Prospective, open label, observational trial. SETTING: A general teaching hospital. METHOD: Three groups of adult subjects (age> 18y) of both sexes were included in this study: control group: 29 healthy volunteers; SBL group: 17 patients with Glasgow Coma Scale (GCS)< 8; and BD group: 11 brain-dead patients. Samples of venous blood were collected in the morning at rest from healthy volunteers and at 8 hourly intervals over a period of 24h from SBL and BD patients for AVP determinations. Concomitantly, some clinical and laboratorial variables were also recorded. RESULTS: AVP serum levels (pg/ml) were [mean (SD); median]: control [2.2(1.1); 2.0]; SBL [5.7(6.3); 2.9]; and BD [2.6(1.0); 2.8]. AVP serum levels varied greatly in SBL patients, but without statistically significant difference in relation to the other groups (p=0.06). Hypotension (p=0.02), hypernatremia (p=0.0001), serum hyperosmolarity (p=0.0001) and urinary hypoosmolarity (p=0.003) were outstanding in BD patients when compared with SBL. CONCLUSIONS: The AVP serum levels did not demonstrate significant statistical difference between the groups, only showing a greater variability in SBL patients (manifested as serum spike levels). Hypernatremia and hyperosmolarity were present in BD patients, indicating a failure of the hypothalamic-pituitary system in AVP production and release.
publishDate 2004
dc.date.none.fl_str_mv 2004-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000200007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2004000200007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0004-282X2004000200007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.62 n.2a 2004
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212756604583936